We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Chad Ritch

Chad R Ritch MD, MBA

Assistant Professor, Department of Urology, University of Miami, Miller School of Medicine, Miami, FL

Dr. Ritch is a fellowship-trained Urologic Oncologist, and currently an Assistant Professor of Urology at the University of Miami, Miller School of Medicine. His clinical interests include the treatment of prostate, bladder, kidney and testicular cancer. His research interests are in prostate and bladder cancer and he serves as PI for a pilot trial investigating the role of nutrition intervention in patients undergoing radical cystectomy. He is a member of the AUA Guideline Panel for the Management of Non-muscle Invasive Bladder Cancer. He did his undergraduate studies at Duke University and then matriculated at the University of Chicago, where he obtained a joint degree in medicine (MD) and business (MBA) from the Pritzker School of Medicine and Booth School of Business. He then completed his residency in Urology at Columbia University Medical Center/NY Presbyterian Hospital followed by a two-year fellowship in Urologic Oncology at Vanderbilt University Medical Center.Dr. Ritch is a fellowship-trained Urologic Oncologist, and currently an Assistant Professor of Urology at the University of Miami, Miller School of Medicine. His clinical interests include the treatment of prostate, bladder, kidney and testicular cancer. His research interests are in prostate and bladder cancer and he serves as PI for a pilot trial investigating the role of nutrition intervention in patients undergoing radical cystectomy. He is a member of the AUA Guideline Panel for the Management of Non-muscle Invasive Bladder Cancer. He did his undergraduate studies at Duke University and then matriculated at the University of Chicago, where he obtained a joint degree in medicine (MD) and business (MBA) from the Pritzker School of Medicine and Booth School of Business. He then completed his residency in Urology at Columbia University Medical Center/NY Presbyterian Hospital followed by a two-year fellowship in Urologic Oncology at Vanderbilt University Medical Center.

Disclosures

No disclosures reported.